Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IOA-244 |
Trade Name | |
Synonyms | IOA 244|roginolisib|IOA244 |
Drug Descriptions |
IOA-244 is a selective PIK3CD inhibitor, which potentially modulates the tumor microenvironment, leading to an antitumor immune response, and inhibits cell proliferation (PMID: 37066023). |
DrugClasses | PIK3CD inhibitor 27 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IOA-244 | IOA-244 | 0 | 1 |
IOA-244 + Rituximab + Venetoclax | IOA-244 Rituximab Venetoclax | 0 | 1 |
IOA-244 + unspecified PD-1 antibody | IOA-244 unspecified PD-1 antibody | 0 | 0 |